Assertio Therapeutics, Inc (ASRT) has 33 open-market insider trades by 15 insiders since 2018. The most active filer is Daniel A. Peisert, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Loan Security Holdings I LLC | 10% Owner | — | 1 | $6.5M | 2020-12-24 |
| CRG Partners III - Parallel Fund (A) L.P. | 10% Owner | — | 1 | $1.4M | 2020-12-22 |
| Heather L. Mason | Dir | — | 3 | $1.4M | 2026-05-13 |
| Daniel A. Peisert | CEOPres | — | 9 | $1.3M | 2023-09-12 |
| Paul Schwichtenberg | CFOVP | — | 2 | $659K | 2026-02-21 |
| Ajay Patel | CAOVP | — | 2 | $404K | 2026-02-21 |
| Sam Schlessinger | CLOVP | — | 1 | $275K | 2026-02-21 |
| Arthur J. Higgins | CEOPresDir | — | 4 | $177K | 2020-12-05 |
| James L. Tyree | Dir | — | 2 | $117K | 2024-03-14 |
| William McKee | Dir | — | 2 | $111K | 2026-05-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Matthew Stark | Director | Sell | $7K | 2025-11-10 |
| Heather L. Mason | Director | Buy | $60K | 2024-11-18 |
| Brendan P. O'Grady | CEO | Buy | $10K | 2024-11-14 |
| Jeff L. Vacirca | Director | Buy | $11K | 2024-06-11 |
| Heather L. Mason | Interim Executive Officer | Buy | $24K | 2024-06-05 |
| James L. Tyree | Director | Sell | $11K |
Companies that share insiders with ASRT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-03-14 |
| Daniel A. Peisert | CEO & President | Sell | $959K | 2023-09-11 |
| Paul Schwichtenberg | CFO & VP | Sell | $645K | 2023-09-11 |
| Ajay Patel | CAO & VP | Sell | $391K | 2023-09-11 |
| Sam Schlessinger | CLO & VP | Sell | $275K | 2023-09-11 |
| William McKee | Director | Sell | $69K | 2023-08-14 |
| Heather L. Mason | Director | Sell | $1.3M | 2023-05-19 |
| James L. Tyree | Director | Sell | $259K | 2023-05-05 |
| William McKee | Director | Sell | $105K | 2022-05-12 |
| James L. Tyree | Director | Sell | $211K | 2022-05-12 |